Erratum to: “Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma” (Clinical Epigenetics, (2016), 8, 1, (1), 10.1186/s13148-015-0167-0);“Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma”

Clinical Epigenetics

Volumn 8, Issue 1, 2016, Pages 1-9

  Quiñonez Silva, Guadalupe ^a   Dávalos Salas, Mercedes ^b   Recillas Targa, Félix ^b   Ostrosky Wegman, Patricia ^c   Aranda, Diego Arenas ^a   Benítez Bribiesca, Luis ^d  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Constitutive epimutation; Genetic epigenetic predisposition; Methylation; RB1 promoter; Sequence variant

Indexed keywords

DNA; MICROSATELLITE DNA; RETINOBLASTOMA PROTEIN;

ADULT; ARTICLE; AUTOSOME; CHILD; CLONING; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EPIMUTATION; FEMALE; GENDER BIAS; GENE; GENE MUTATION; GENE SEGREGATION; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; MALE; MICROSATELLITE MARKER; PEDIGREE; PENETRANCE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RB1 GENE; RETINOBLASTOMA; ALLELE; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GERM CELL; HETEROZYGOTE; INFANT; METABOLISM; MICROBIOLOGY; POINT MUTATION; PRESCHOOL CHILD; RETINA TUMOR;

ALLELES; CHILD, PRESCHOOL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM CELLS; HETEROZYGOTE; HUMANS; INFANT; MALE; MICROSATELLITE REPEATS; PEDIGREE; POINT MUTATION; PROMOTER REGIONS, GENETIC; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN;

EID: 84954217538     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-017-0323-9     Document Type: Erratum

References (35)

1. Broaddus E, Topham A, Sing AD. Incidence of retinoblastoma in the USA 1975–2004. Br J Ophthalmol. 2009;3:21–3.
2. Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820–3.
3. Lohmann DR, Gallie BL. Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet. 2004;129C(1):23–8.
4. Kato MV, Ishizaki K, Shimizu T, Ejima Y, Tanooka H, Takayama J, et al. Parental origin of germline and somatic mutations in the retinoblastoma gene. Hum Genet. 1994;94:31–8.
5. Leach RJ, Magewu AN, Buckley JD, Benedict WF, Rother C, Murphree AL, et al. Preferential retention of paternal alleles in human retinoblastoma: evidence for genomic imprinting. Cell Growth Differ. 1990;1(9):401–6.
6. Munier F, Spence MA, Pescia G, Balmer A, Gailloud C, Thonney F, et al. Paternal selection favoring mutant alleles of the retinoblastoma susceptibility gene. Hum Genet. 1992;9(5):508–12.
7. Kanber D, Berulava T, Ammerphol O, Mitter D, Richter J, Siebert R, et al. The human retinoblastoma gene is imprinted. Plos Genet. 2009;5(12):e1000790.
8. Greger V, Passarge E, Höping W, Messmer E, Horsthemke B. Epigenetic changes contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet. 1989;83:155–8.
9. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet. 1991;48(5):880–8.
10. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene. 1993;8(4):1063–7.
11. De La Rosa-Velázquez IA, Rincón Arana H, Benítez-Bribiesca L, Recillas-Targa F. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. Cancer Res. 2007;67:2577–85.
12. Dávalos Salas M, Furlan-Magaril M, González Buendía E, Valdes-Quezada C, Ayala-Ortega E, Recillas-Targa F. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter. BMC Cancer. 2011;11:232.
13. Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 1997;57(11):2229–37.
14. Ohtani-Fujita N, Dryja TP, Rapaport JM, Fujita T, Matsumara S, Ozaka K, et al. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet. 1977;98:43–9.
15. Yu C, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Fraumeni Jr JF. Cause-specific mortality in long-term survivors of retinoblastoma. JNatl Cancer Inst. 2009;101(8):581–91.
16. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 2000;15:7–12.
17. Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP. Oncogenic germline mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature. 1991;353:83–6.
18. Ohtani-Fujita N, Fujita T, Takahashi R, Robbins PD, Dryja TP, Sakai T. A silencer element in the retinoblastoma tumor-suppressor gene. Oncogene. 1994;9(6):1703–11.
19. Savoysky E, Mizuno T, Sowa Y, Watanabe H, Sawada J, Nomura H, et al. The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family. Oncogene. 1994;9(7):1839–46.
20. Cowell JK, Bia B, Akoulitchev A. A novel mutation in the promotor region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene. Oncogene. 1996;12(2):431–6.
21. Short Tandem Repeat DNA Internet DataBase. http://www.cstl.nist.gov/strbase/str_d13s.htm. Accessed 20 July 2015
22. Ensembl 2015. http://www.ensembl.org/Homo_sapiens/Marker/Details?m=SHGC-4544. Accessed July 2015
23. Naumova A, Sapienza C. The genetics of retinoblastoma, revisited. Am J Hum Genet. 1994;54(2):264–73.
24. Klutz M, Brockman D, Lohmann DR. A parent-of-origin effect in two families with retinoblastoma is associated with a distinct splice mutation in the RB1 gene. Am J Hum Genet. 2002;71:174–9.
25. Homo sapiens:GRCh38.p2 (GCF_000001405.28)Chr 13 (NC_000013.11):48.30M - 48.30M. http://www.ncbi.nlm.nih.gov/variation/view/?q=rs387906520. Accessed November 2015.
26. RB1 homepage - rb1-lsdb - Leiden Open Variation Database. http://rb1-lsdb.d-lohmann.de/home.php?select_db=RB1
27. Agromayor M, Wloga E, Naglieri B, Abrashkin J, Verma K, Yamasaki L. Visualizing dynamic E2F-mediated repression in vivo. Mol Cell Biol. 2006;26(12):4448–61.
28. Ligtenberg MJ, Kuiper RP, Chan TL, Goosens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3’ exons TACSTD1. Nat Genet. 2009;41(1):112–7.
29. Barbour VM, Tufarelli C, Sharpe JA, Smith ZE, Ayyub H, Heinlein CA, et al. Alpha-thalassemia resulting from a negative chromosomal position effect. Blood. 2000;96(3):800–7.
30. Raval A, Tanger SM, Byr JCAngeman EB, Perko JD, Chen S-S, Hackanson B, et al. Down regulation of death associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 2007;129(5):879–90.
31. Tuffarelli C, Stanley JAS, Garrick D, Sharpe JA, Ayyub H, Wood WG, et al. Transcription of antisense RNA leading to genetic silencing and methylation as a novel cause of human gene disease. Nat Genet. 2003;34(2):157–65.
32. Hesson LB, HitchinsMP WRL. Epimutations and cancer predisposition: importance and mechanisms. Curr Op Genet Dev. 2010;20:290–8.
33. Hitchins MP. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility. Adv Genet. 2010;70:201–43.
34. Gustmann S, Klein-Hitpass L, Stephan H, Weber S, Bornfeld N, Kaulisch M, et al. Loss at chromosome arm 16q in retinoblastoma: confirmation of the association with diffuse vitreous seeding and refinement of the recurrently deleted region. Genes Chromosomes Cancer. 2011;50(5):327–37.
35. Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet. 2004;41:801–7.